Diabetes Market Research Reports & Industry Analysis

The notion “diabetes” refers to a disease impacting the body’s ability to produce/use insulin. At present, more than 365 million people suffer from the disease worldwide. By 2030, the figure may reach 550 million. Inappropriate eating habits combined with a sedentary lifestyle, growth of the diabetic population and an increase in the number of obesity cases are amid the main factors contributing to the diabetes market growth. The list of the products available on the market is extensive: continuous blood glucose meters, anti-diabetic drugs, insulin and insulin pumps, artificial pancreas devices, etc.

Evaluated at over USD 19.8 billion, North America represents the top market, while Europe acts as the second largest player. The global diabetes market is expected to be at approximately USD 100 billion in 2018, showing a twofold increase if compared to 2011.

The Catalogue includes research reports dedicated to the diabetes market. The studies describe past and current industry trends, disclose data on the market competition and profile top industry behemoths. Information on the upcoming market events, industry growth drivers and hindrances can be found in the reports, too. Besides, the research reports contain evaluation of the actual economic situation, analyses of the market prospects.

Found 119 publications
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 US$ 3,995.00 US$ 3,196.00

... provides an overview of the pipeline landscape for diabetes and associated metabolic conditions. It provides comprehensive information on the therapeutics ... targets acted on by products in development for diabetes and associated metabolic conditions include the insulin receptor, glucagon-like peptide 1 ...

Jun, 2018 344 pages
Global Human Insulin Market 2018-2024 US$ 2,750.00

... for the manufacturers of human insulin. Market Analysis: The “Global Human Insulin” market is estimated to witness a CAGR of 10.2% during the forecast period 2017–2023. The human insulin market is analyzed based on three ...

Feb, 2018 77 pages
Global Artificial Intelligence in Diabetes Management Market: Drivers, Restraints, Opportunities, Trends, and Forecasts to 2023 US$ 3,500.00

... within 20 years. Market Analysis According to Infoholic Research, the “Global Artificial Intelligence in Diabetes Management” market is expected to grow at a CAGR of 50.7% ... Benefits The study covers and analyzes the “Global Artificial Intelligence in Diabetes Management” market. Bringing out the complete key ...

Feb, 2018 82 pages
U.S. Next Generation Diabetes Therapy and Drug Delivery Market by Product Type (Inhalable Insulin, Oral Insulin, Insulin Patch, CGM System, and Artificial Pancreas), Demographic (Adult... US$ 3,255.00

... skin irritation due to frequent use of needles. The U.S. next generation diabetes therapy and drug delivery market is segmented based on product type, ... analysis of the key developments in the industry. The U.S. next generation diabetes therapy and drug delivery market is comprehensively analyzed with respect to ...

Apr, 2018 124 pages
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including... US$ 6,995.00 US$ 5,596.00

... , alongside increases in obesity due to lifestyle changes in the 21st century. Type 2 diabetes is characterized by insulin resistance leading to dysregulation of glucose control and chronic hyperglycemia. This leads to several ...

Apr, 2018 77 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (US) 2018 US$ 6,365.00

... the ways you can improve your medical affairs services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (US). Comparing 9 major oral Type 2 Diabetes Mellitus treatments from AstraZeneca ...

Feb, 2018
Medical Affairs Reputations: Type 2 Diabetes Mellitus [Orals] (EU5) 2018 US$ 6,365.00

... the market leader In the EU5, several of the Type 2 Diabetes Mellitus medical affairs teams we surveyed are running neck and neck with ... ways you can improve your medical affair services in Medical Affairs Reputations: Type 2 Diabetes Mellitus (Orals) (EU5). Comparing 9 major Type 2 Diabetes Mellitus (Orals) ...

Feb, 2018
Type 2 Diabetes: Competitive Landscape to 2026 US$ 3,495.00 US$ 2,796.00

Type 2 Diabetes: Competitive Landscape to 2026 SUMMARY Type 2 Diabetes (T2D) is a chronic disease characterized by insulin resistance and ... impact the global Type 2 Diabetes (T2D) market in the future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing ...

Mar, 2018 51 pages
The 2019-2024 World Outlook for Diabetic Nephropathy Therapeutics US$ 995.00

This study covers the world outlook for diabetic nephropathy therapeutics across more than 190 countries. For each year reported, ... demand, or the P.I.E., for diabetic nephropathy therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

Jan, 2018 269 pages
India Diabetes Market Report 2017 US$ 2,350.00

... still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 ... ) Channel (Direct Sales, Distributor) Segmentation Section 7: 400 USD - Trend (2017-2021) Section 8: 300 USD - Product Type Detail Section 9: 700 ...

Dec, 2017 126 pages
Medical Affairs Reputations: Type 2 Diabetes Mellitus (US) US$ 6,175.00

Find out what the leading medical affairs teams in type 2 diabetes are doing right Medical affairs teams for several leading T2DM treatments in the US ... your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (US). Comparing 11 major melanoma treatments from ...

Jul, 2017
Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5) US$ 6,175.00

... what your team gets right, and where it’s going wrong in Medical Affairs Reputations: Type 2 Diabetes Mellitus (EU5). Comparing 7 major melanoma treatments from Novo ...

Jul, 2017
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes US$ 4,995.00 US$ 3,996.00

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape ... the diversifying and highly lucrative diabetes mellitus (DM) market. Analysis has identified a high level of ... review of products, segmented by stage of development, molecule type and molecular target - as well as detailed profile assessments ...

Sep, 2017 137 pages
Gestational Diabetes Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Aug, 2017 133 pages
Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017 SUMMARY GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2017' provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report ...

Aug, 2017 283 pages
Diabetic Retinopathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 244 pages
Diabetic Peripheral Neuropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 126 pages
Diabetic Neuropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 249 pages
Diabetic Neuropathic Pain Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 122 pages
Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 49 pages
Diabetic Nephropathy Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 317 pages
Diabetic Macular Edema Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 316 pages
Diabetic Ketoacidosis Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 48 pages
Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 65 pages
Diabetic Foot Ulcers Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...

Jul, 2017 179 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 62 pages
Diabetes Insipidus Global Clinical Trials Review, H2, 2017 US$ 2,500.00 US$ 2,000.00

... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...

Jul, 2017 45 pages
Diabetic Gastroparesis Forecast in 12 Major Markets 2017-2027 US$ 6,150.00

... also included at a country level across the 10-year forecast snapshot. These gastrointestinal symptoms include: Nausea ... impact from specific co-morbid conditions on Diabetic Gastroparesis prevalent population. Identify sub-populations within Diabetic Gastroparesis which require treatment. Gain an understanding ...

Apr, 2017 50 pages
Indian Diabetes Market Research and Analysis, 2015-2022 US$ 3,495.00

... India, Pfizer India, Sanofi Aventis, Sun Pharmaceuticals, USV India. Market Segments 1. INDIAN DIABETES MARKET BY TYPE 2. INDIAN DIABETES MARKET BY DRUG CLASS 3. INDIAN DIABETES MARKET BY DEVICES OMR REPORT COVERS: Comprehensive research methodology of Global Indian Diabetes Market ...

May, 2017
The 2019-2024 World Outlook for Diabetic Macular Edema (DME) Treatments US$ 995.00

This study covers the world outlook for diabetic macular edema (DME) treatments across more than 190 countries. For each year ... demand, or the P.I.E., for diabetic macular edema (DME) treatments. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also ...

Jan, 2018 272 pages
The 2019-2024 World Outlook for Diabetic Food US$ 995.00

This study covers the world outlook for diabetic food across more than 190 countries. For each year ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Diabetes Therapeutics and Diagnostics US$ 995.00

This study covers the world outlook for diabetes therapeutics and diagnostics across more than 190 countries. For each year reported, ... demand, or the P.I.E., for diabetes therapeutics and diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...

Jan, 2018 270 pages
The 2019-2024 World Outlook for Diabetes Monitoring, Treatment, and Drug Delivery Products US$ 995.00

This study covers the world outlook for diabetes monitoring, treatment, and drug delivery products across more than 190 countries ... the P.I.E., for diabetes monitoring, treatment, and drug delivery products. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 283 pages
The 2019-2024 World Outlook for Diabetes Drugs US$ 995.00

This study covers the world outlook for diabetes drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for diabetes drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Diabetes Diagnostics US$ 995.00

This study covers the world outlook for diabetes diagnostics across more than ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for diabetes diagnostics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Diabetes Diagnosis, Treatment, and Drug Delivery Devices US$ 995.00

This study covers the world outlook for diabetes diagnosis, treatment, and drug delivery devices across more than 190 countries. ... the P.I.E., for diabetes diagnosis, treatment, and drug delivery devices. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...

Jan, 2018 283 pages
The 2019-2024 World Outlook for Diabetes Devices and Drugs US$ 995.00

This study covers the world outlook for diabetes devices and drugs across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... P.I.E., for diabetes devices and drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Diabetes Devices US$ 995.00

This study covers the world outlook for diabetes devices across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for diabetes devices. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
The 2019-2024 World Outlook for Diabetes Care Devices US$ 995.00

This study covers the world outlook for diabetes care devices across more than ... not discuss the specific players in the market serving the latent demand, nor specific ... the P.I.E., for diabetes care devices. It also shows how the P.I.E. is divided across the world's regional and national markets. For each ...

Jan, 2018 268 pages
Type 1 Diabetes Mellitus Forecast in 12 Major Markets 2017-2027 US$ 6,150.00

... at a country level across the 10-year forecast snapshot. There are many co-morbidities associated with Type 1 Diabetes Mellitus, including: Chronic pancreatitis Cystic fibrosis Autoimmune ... on the impact from specific co-morbid conditions on Type 1 Diabetes Mellitus prevalent population. Identify sub-populations within Type 1 Diabetes Mellitus which require treatment. Gain an understanding of the ...

Mar, 2017 54 pages
OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 US$ 10,995.00 US$ 8,796.00

OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecast to 2025 SUMMARY GlobalData estimates sales of diabetic foot ulcer (DFU) and diabetic foot infection (DFI) drugs to be approximately $292.1M across the ... most lucrative within the DFU space? Key Findings Prevalence of diabetes and resulting DFUs, DFIs are increasing across the 7MM ...

Dec, 2016 166 pages
Global Diabetes Market: Industry Analysis & Outlook (2016-2020) US$ 800.00

... be seen during pregnancy. The report “Global Diabetes Market” provides an in-depth analysis of the global diabetes market, along with the regional markets. The major trends, growth drivers as well ... are being profiled. The key factors driving the growth of diabetes market are growing ageing population, growing urbanization, increasing healthcare expenditure ...

Dec, 2016 107 pages
Global Diabetes Market Research and Analysis, 2014-2020 US$ 3,495.00

Market Insight Global Diabetes Market is expected to grow at a CAGR of 8.1 percent for the forecasted period of 2015-2020. The market is segmented on the basis of type of diabetes, drugs class and ...

May, 2016 140 pages
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 US$ 10,995.00 US$ 8,796.00

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2026 SUMMARY While ... ’ efforts to delay disease progression and reduce the costly burden of diabetic complications through the use of combination therapies and novel branded ...

Jul, 2017 377 pages
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth US$ 4,995.00 US$ 3,996.00

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth SUMMARY Diabetes mellitus ... range of treatment options, including biguanide (metformin), sulfonylureas, thiazolidinediones, GLP-1 receptor ...

Oct, 2017 202 pages
Global Diabetic Food Market Report 2016 US$ 2,850.00

2016 Global Diabetic Food Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetic Food industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetic Food industry; 3.) the North American Diabetic Food industry; 4.) the European Diabetic Food industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Global Diabetes Management Market Report 2016 US$ 2,850.00

2016 Global Diabetes Management Report is a professional and in-depth research report on the world's major regional market conditions of the Diabetes Management industry, focusing on the main regions ... with: 1.) basic information; 2.) the Asia Diabetes Management industry; 3.) the North American Diabetes Management industry; 4.) the European Diabetes Management industry; 5.) market entry and investment feasibility; and ...

Aug, 2016 146 pages
Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies US$ 6,995.00 US$ 5,596.00

Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies Summary Diabetes is a common long-term condition that can ...

Jun, 2016 73 pages
Diabetic Nephropathy Global Clinical Trials Review, H1, 2016 US$ 2,500.00 US$ 2,000.00

... clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial ...

May, 2016 309 pages
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016 US$ 2,500.00 US$ 2,000.00

... clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016' provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI ...

May, 2016 58 pages
1 2 3 >
Skip to top